Automated Molecular Diagnostics Testing System Market Growth and Segm FMI | Page 6

Report
Description
Report Description
The adoption rate of personalized medicine is also very high in the U.S. and EU5 countries
which is boosting the automated molecular diagnostic testing market. APAC region is
expected exhibit significant growth in terms of revenue over the forecast period. The
large number of research centers in China and India and R&D centers in Japan will lead to
rise in demand for high quality of molecular diagnostics which is ultimately expected to
boost the demand of automated molecular diagnostic testing systems in the APAC region
during the forecast period.
Some key participants in the automated molecular diagnostic market are Roche Holding
AG, Abbott Laboratories, Becton Dickenson & Company, Siemens Healthcare GmbH,
Enigma Diagnostics Ltd., Qiagen, Bio-Rad Laboratories, Inc., Cepheid Inc. and
PerkinElmer Inc., AutoGenomics, ELITech Group.